8月7日,礼来发布2025H1业绩,上半年营收282.862亿美元,同比增长41%。在已披露业绩的制药巨头中,礼来总营收排名第6,制药业务营收排名第4,位次相比2024年同期变动较大。全球药企2025H1总营收排名TOP13(亿美元)从地区分布来看,2025年前六个月美国市场收入193.04亿美元(+43%),欧洲市场收入49.63亿美元(+74%),日本市场收入9.23亿美元(+11%),...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.